Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease

Participant-informant relationships may modulate informant responses on subjective measures such as the QOL-AD in both incipient and clinical AD. Clinical trials that use informant measures may need to address these effects.